Compass Therapeutics, Inc.
(CMPX - NASDAQ)
1,79 USD
📋 Profilo Aziendale

Compass Therapeutics, Inc., a clinical-stage oncology-focused biopharmaceutical company, engages in developing antibody-based therapeutics to treat various human diseases.

|